Memorial Sloan-Kettering Cancer Center
Learn more about Memorial Sloan-Kettering Cancer Center
The Memorial Sloan-Kettering Cancer Center (MSKCC) in New York City is a cancer treatment and research institution founded in 1884 as the New York Cancer Hospital. The main campus is located at 1275 York Avenue, between 67th and 68th Streets, with other locations in New Jersey, Long Island and West Chester, New York. The original Memorial Hospital building was constructed in 1939 by a group that included John J. Astor and his wife, Charlotte. Between 1970 and 1973 a new memorial hospital was built on the same site - originally donated by John D. Rockefeller, Jr.
MSKCC is actually composed of two intimately-related institutions. Memorial Hospital for Cancer and Allied Diseases provides patient care, while Sloan-Kettering Institute is MSKCC's basic-science research arm. The research institute was established in 1945 with a $4 million gift from the foundation of Alfred P. Sloan, Jr. Half the gift was to fund construction of a 13-story research facility and the other half to provide annual operating expenses. Charles F. Kettering, vice president and director of research for General Motors Corporation, was to organize and apply modern American industrial research techniques to cancer research.
In addition to the Sloan grant, a public campaign to raise an additional $3 million to $4 million was undertaken and an important financier who stepped in at a critical juncture was the ongoing supporter Laurance Rockefeller, of the philanthropic Rockefeller family.
At the August 8, 1945 announcement, Sloan and Kettering emphasized that the dramatic news of the atomic bomb, developed with a $2 billion research program, was a graphic illustration of what can be accomplished by scientifically-organized research as practiced by American industry. If as much money and talented personnel were available as the Government had had for the atomic bomb, they said, very rapid progress could be made in cancer research.
MSKCC has long been a leader in cancer surgery, chemotherapy, and radiotherapy. It was the first to develop services specifically dedicated to the psychiatric aspects of cancer, to the relief of cancer pain, and to genetic counseling. U.S. News & World Report ranks MSKCC as the best cancer hospital in the country. Since that particular rating service began, only M. D. Anderson Hospital in Houston has rivaled MSKCC.
MSKCC is affiliated with the Weill Medical College of Cornell University and the Tri-Institutional MD/PhD program, which includes MSKCC as one of its three sites (along with Weill-Cornell and Rockefeller University). MSKCC and Weill-Cornell operate a joint graduate program in biomedical sciences. In 2006, MSKCC also established an independent graduate school, with a Ph.D. program in cancer biology: the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences.
The current president of Memorial Sloan-Kettering is Nobel Prize winner Harold E. Varmus. In 2006 the center was one of six institutes (along with research centers at Harvard University, the Massachusetts Institute of Technology, Johns Hopkins University, the University of Chicago, and Stanford University) selected to receive a $20 million grant for cancer research from the Ludwig Fund, created by the American billionaire Daniel K. Ludwig. The grant, one of the largest earmarked for cancer research the hospital has ever received, will be used for immunology research.
 External links
- Official website
- Cancer-help.org - Recent mentions in the online press
- Weill Graduate School of Biomedical Sciences
- Gerstner Sloan-Kettering Graduate School of Biomedical Sciences
- Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program
- MSKCC Marathon Program
- Wikimapia aerial view of Memorial Sloan-Kettering Cancer Center main location in New York City
- "Sloan, Kettering to Combat Cancer", New York Times, August 8, 1945, p. 1 (cont'd pg 40).